1Department of Biology, Boston University, Boston, MA 02215, USA. gilmore@bu.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Multiple myeloma tumor cells rely on a signaling pathway called NF-kappaB for survival. Mutations in this pathway are common in multiple myeloma, making it a promising therapeutic target.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: